AXC-715 trihydrochloride

Modify Date: 2024-01-02 17:06:19

AXC-715 trihydrochloride Structure
AXC-715 trihydrochloride structure
Common Name AXC-715 trihydrochloride
CAS Number 2479276-17-8 Molecular Weight 420.81
Density N/A Boiling Point N/A
Molecular Formula C18H28Cl3N5 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of AXC-715 trihydrochloride


AXC-715 trihydrochloride is a TLR7/TLR8 dual agonist, extracted from patent WO2020168017 A1[1]. AXC-715 trihydrochloride, compound D from WO2020190734A1, can be used for synthesis of antibody-adjuvant immunoconjugates, comprising an antibody construct that binds programmed death-ligand 1 (PD-L1) linked to one or more adjuvants[2].

 Names

Name AXC-715 trihydrochloride

 AXC-715 trihydrochloride Biological Activity

Description AXC-715 trihydrochloride is a TLR7/TLR8 dual agonist, extracted from patent WO2020168017 A1[1]. AXC-715 trihydrochloride, compound D from WO2020190734A1, can be used for synthesis of antibody-adjuvant immunoconjugates, comprising an antibody construct that binds programmed death-ligand 1 (PD-L1) linked to one or more adjuvants[2].
Related Catalog
Target

TLR7/TLR8[1]

References

[1]. Sung-Ju Moon, et al. Compositions containing, methods and uses of antibody-tlr agonist conjugates. Patent WO2020168017A1.

[2]. Shelley Erin ACKERMAN, et al. Immunoconjugates targeting pd-l1. Patent WO2020190734A1.

 Chemical & Physical Properties

Molecular Formula C18H28Cl3N5
Molecular Weight 420.81